Episode Summary
Executive Summary: Andrew Huberman and Dr. Kyle Gillette discuss hormone optimization as a lifespan strategy built on lifestyle first, then targeted testing, supplements, and hormone therapies when appropriate. They cover testosterone, estrogen, DHT, prolactin, growth hormone, PCOS, prostate health, fertility, sleep, and peptides, emphasizing individualized care, bloodwork, and avoiding overcorrection.
Main Topics: Foundations of hormone health (Priority: 5/5): Gillette frames hormone optimization around six pillars: diet, exercise, stress management, sleep, sunlight, and spirit, with lifestyle changes as the highest-value interventions before medications or hormones. Testosterone, estrogen, and DHT balance (Priority: 5/5): The conversation explains how testosterone, estrogen, SHBG, and DHT interact in men and women, including how body fat, aromatase, genetics, and supplements can shift these pathways. Caloric restriction, fasting, and exercise (Priority: 5/5): They distinguish between obese and lean individuals: caloric restriction can improve testosterone in obesity/metabolic syndrome but may lower testosterone in young healthy men; resistance training and zone 2 cardio are emphasized. Female hormone health and PCOS (Priority: 4/5): Gillette outlines how women can assess hormone issues through menstrual patterns, androgen excess, insulin resistance, and fertility concerns, and discusses PCOS treatments such as metformin, myo-inositol, and d-chiro-inositol. Prostate health, sleep, and TRT (Priority: 4/5): They discuss testosterone replacement therapy, sleep apnea risk, prostate monitoring, and how prostate health is influenced by inflammation, blood flow, constipation, and medications like tadalafil and finasteride. Supplements and peptides (Priority: 4/5): The episode reviews tongkat ali, fadogia agrestis, boron, creatine, L-carnitine, HCG, and peptides such as BPC-157, GHK-copper, and melanotan, stressing evidence, cycling, and caution. Prolactin, dopamine, and relationships (Priority: 3/5): Huberman and Gillette connect prolactin and dopamine to libido, motivation, postpartum changes, and relationship dynamics, arguing that time apart and reunion can help preserve attraction.
Key Arguments: Hormone optimization should start with lifestyle: diet, resistance training, sleep, stress reduction, sunlight, and spiritual/meaning-based health. Caloric restriction is beneficial for testosterone mainly in people with obesity or metabolic syndrome; in lean healthy men it can reduce testosterone. Women often have underrecognized hormone issues because menstrual changes provide clearer symptoms than men’s more subtle libido/energy changes. DHT is not inherently bad; it supports motivation, libido, and tissue function, but excess signaling can contribute to hair loss and prostate issues in susceptible people. Supplements like curcumin, saw palmetto, and some anti-androgenic compounds can lower DHT or androgen signaling and may worsen energy/libido in some users. Creatine may increase DHT and can be useful for performance and possibly cognition, but may also worsen hair loss in genetically susceptible individuals. Oral contraceptives alter SHBG and free testosterone/free DHT, which can change libido and perceived attractiveness without permanently changing a person. TRT should be individualized and monitored; frequent smaller doses or steady-state delivery are preferred over large infrequent peaks and crashes. Testosterone does not cause prostate cancer, but it can accelerate growth of existing prostate cancer, so monitoring matters. Prolactin is not just a 'bad' hormone; it supports breastfeeding, nesting, and infant lung maturation, while excess prolactin can suppress libido and testosterone. Peptides are highly heterogeneous; some are clinically useful, but many should only be used with medical supervision because of cancer, vascular, or endocrine risks.
Data Points: Big pillars of hormone health: 6 - Gillette’s framework: diet, exercise, stress, sleep, sunlight, spirit. Strongest lifestyle pillars: 2 - Diet and exercise were described as the most powerful interventions. Recommended zone 2 cardio: 150 to 180 minutes per week - Huberman referenced this as a minimum target for cardiovascular, brain, and musculoskeletal health. Blood testing frequency: Every 3 to 6 months - Gillette recommended this for preventive monitoring, with faster testing when needed. Weight loss composition: About 33% lean body mass - He noted that weight loss includes substantial lean mass loss, not just fat. Obesity-related testosterone effect: Improves testosterone in obese individuals - Caloric restriction tends to improve testosterone when obesity/metabolic syndrome is present. Young healthy men on caloric restriction: Testosterone decreases - He cited a systematic review noting testosterone decline in young healthy men under restriction. Growth hormone half-life: Hours - Used to contrast growth hormone with IGF-1’s longer duration. IGF-1 half-life: Several days, almost a week - Explained as a longer-acting downstream mediator of growth hormone. PCOS prevalence: 10% to 20% - Gillette said prevalence is likely underdiagnosed and varies by study. Infertility evaluation threshold: 1 year under age 35; 6 months over age 35 - He gave standard fertility timelines for when to seek evaluation. PSA concern threshold: 4 or less ideally - He noted PSA interpretation depends on age and context, not just the absolute number. Typical TRT dose: 100 to 120 mg per week - He described this as a common replacement range, usually split into 2 to 3 doses. HCG fertility dose: 10,000 IU at one time - He described this as a common fertility-related dose, much higher than many expect. Boron dose: 3 to 6 mg once to twice daily - Used to help regulate SHBG acutely. L-carnitine fertility dose: 1 gram per day - He linked this to fertility and androgen receptor upregulation, noting oral bioavailability is low. Oral L-carnitine bioavailability: About 10% - He said oral forms are poorly bioavailable compared with injection. Garlic/allicin dose for TMAO mitigation: 600 mg - Huberman referenced using garlic to reduce TMAO when taking carnitine. Tongkat ali cycle suggestion: 11 months on, 1 month off - Gillette suggested cycling as a cautious approach. Fadogia cycle suggestion: 3 weeks on, 1 week off - Recommended due to limited long-term safety data. Calcium D-glucarate dose: 500 to 1000 mg - Suggested for estrogen control, though not as potent as aromatase inhibitors. Prolactin concern level: Under about 40 - He suggested prolactin below this is often not a major issue absent symptoms.
Pivotal Quotes: "The law of diminishing returns applies." — Dr. Kyle Gillette: He used this to explain why small, consistent lifestyle changes outperform extreme short-term efforts. "If you're obese or you have metabolic syndrome, caloric restriction will improve your testosterone." — Dr. Kyle Gillette: He contrasted obese versus lean individuals to clarify when restriction helps or hurts hormones. "Testosterone is not going to cause a prostate cancer. However, normal aging causes prostate cancer and testosterone will grow your prostate cancer." — Dr. Kyle Gillette: He addressed a common fear about TRT and prostate risk.
Implications: Listeners should prioritize lifestyle, get periodic bloodwork, and treat supplements/hormones as tools requiring individualized monitoring. The episode also suggests growing demand for nuanced, evidence-based hormone care across men and women.
About The Huberman Lab
The Huberman Lab podcast is hosted by Andrew Huberman, Ph.D., a neuroscientist and tenured professor in the department of neurobiology, and by courtesy, psychiatry and behavioral sciences at Stanford School of Medicine. The podcast discusses neuroscience and science-based tools, including how our brain and its connections with the organs of our body control our perceptions, our behaviors, and our health, as well as existing and emerging tools for measuring and changing how our nervous system works. Huberman has made numerous significant contributions to the fields of brain development, brain function, and neural plasticity, which is the ability of our nervous system to rewire and learn new behaviors, skills, and cognitive functioning. He is a McKnight Foundation and Pew Foundation Fellow and was awarded the Cogan Award, given to the scientist making the most significant discoveries in the study of vision, in 2017. Work from the Huberman Laboratory at Stanford School of Medicine has been published in top journals, including Nature, Science, and Cell, and has been featured in TIME, BBC, Scientific American, Discover, and other top media outlets. In 2021, Dr. Huberman launched the Huberman Lab podcast. The podcast is frequently ranked in the top 10 of all podcasts globally and is often ranked #1 in the categories of Science, Education, and Health & Fitness.